IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation

Go back to IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
(NASDAQ: ICCM) Delayed: 1.95 -0.01 (0.51%)
Previous Close $1.96    52 Week High
Open $1.99    52 Week Low
Day High $2.08    P/E N/A 
Day Low $1.95    EPS
Volume 70,959